Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Spotlight On Retina: A Case Study

By: Rishi P. Singh, MD; W. Lloyd Clark, MD; Diana V. Do, MD; Quan Dong Nguyen, MD, Msc

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

Expiration Date: Monday, April 30, 2018
Release Date: April 2017

Learning Objectives

Upon completion of this educational program, attendees should be able to:

  • Describe the long-term outcomes of VEGF-inhibitor use and practice patterns in the management of AMD.
  • Distinguish the differences in the reported long-term outcomes of each study.
  • Determine how to apply this data to clinical practice and patient education regarding long-term management of wet AMD.

Accreditation and Designation Statement

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC and Avlis International, Inc.

AMA Credit Designation Statement

Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Faculty and Disclosures

The following faculty members have the following financial relationships with commercial interests:

Rishi P. Singh, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Carl Zeiss Meditec; Genentech, Inc; Optos; Regeneron Pharmaceuticals, Inc; and Shire Plc. Grant/Research Support: Alcon; Apellis Pharmaceuticals; Genentech, Inc; and Regeneron Pharmaceuticals, Inc.

Lloyd Clark, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Bayer Pharmaceuticals; Genentech, Inc; Ohr Pharmaceutical, Inc.; and Santen Pharmaceutical Co. Grant/Research Support: Allergan Plc; Genentech, Inc; Ohr Pharmaceutical, Inc.; Regeneron Pharmaceuticals, Inc.; and Santen Pharmaceutical Co.

Diana V. Do, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Genentech, Inc and Santen Pharmaceutical Co. Grant/Research Support:  Genentech, Inc; Regeneron Pharmaceuticals, Inc.; and Santen Pharmaceutical Co.

Quan Dong Nguyen, MD, Msc has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: AbbVie; Daichii; Genentech, Inc and Santen Pharmaceutical Co. . Grant/Research Support:  Genentech, Inc; Novartis Pharmaceuticals; Opthotech Corporation; Plsvida; Regeneron Pharmaceuticals, Inc.; and Santen Pharmaceutical Co.

Editorial Support Disclosure

Fabiana Queiroga Silva, Peer Reviewer; Sue Silva, Avlis International, Inc.; and Cheryl Cavanaugh, MS, Evolve Medical Education LLC have no real or apparent conflicts of interest to report.

Video Resources

Spotlight on Retina: A Case Study

By: Rishi P. Singh, MD; W. Lloyd Clark, MD; Diana V. Do, MD; Quan Dong Nguyen, MD, Msc

BackNext